Preload Image

Foquest is now listed on the PEI Formulary

Foquest is now listed on the PEI Formulary caddra December 19, 2023

Effective December 18, 2023, Foquest is listed on the PEI Formulary (special authorization) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Learn more about the eligibility criteria for reimbursement of Foquest in PEI.

Scroll to Top